LDS/Medical Tests/Carbamazepine, Free and Total, Serum

Carbamazepine, Free and Total, Serum

Epilepsy is a chronic long-term condition which can be treated by the use of antiepileptic drugs. Carbamazepine is an antiepileptic (anticonvulsant) drug, which works to suppress central nervous system activity. It is used in the treatment of generalized tonic-clonic (grand mal) seizures, psychomotor seizures, and for treating pain associated with trigeminal neuralgia (inflammation of the facial nerve). It has also been used to treat mental illness, depression, and diabetes insipidus.

Carbamazepine is given orally (by mouth) in either a pill form, or a liquid suspension. It is absorbed in the GI (gastrointestinal) tract, metabolized by the liver, and excreted in the urine. It shows a half-life of 10-30 hours. Peak serum levels are reached in 2–24 hours depending on individual metabolism rates. Anywhere from 20 to 80 percent of the drug is found bound to albumin. The most prevalent metabolite is 10,11-epoxide, which shows therapeutic and toxic activity. Hepatic (liver) function testing may be monitored for early signs of serum toxicity. Toxic levels (>20 mg/mL) induce adverse neurosensory effects including blurred vision, diplopia (double vision), and lack of motor control (ataxia). Other signs of toxicity may include irregular breathing, tachychardia, and impaired consciousness. Studies have found that carbamazepine will decrease the effectiveness of some drugs when taken concurrently, especially oral contraceptives.

  • Monitor patients receiving Carbamazepine therapy
  • Aid in diagnosing/monitor Carbamazepine overdose and prevention of Carbamazepine toxicity
  • Compliance assessment

Increased in:

  • Serum toxicity with Carbamazepine
  • Patient taking Carbamazepine

Therapeutic range: 4 - 12 mg/mL [17-51 mmol/L]
Toxic Concentration >15 mg/mL [>63 mmol/L]

 

 

Enzyme immunoassay (EIA), Fluorescent polarization immunoassay (FPIA), High performance liquid chromatography (HPLC), Gas chromatography/mass Spectrophotometry (GC/MS), Enzyme-multiplied immunoassay technique (EMIT).

Serum (Red) or Plasma EDTA (Lavender) Heparin (Green). 

Stability

Stability

  • Ambient: 3-5
  • Refrigeration: 7-14 days
  • Frozen: 30 days
Liver Panel, Complete Blood Count (CBC), Free Carbamazepine.

13 days.

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Epilepsia. 2011 Jan 4. doi: 10.1111/j.1528-1167.2010.02917. [PMID: 21204827]
  • J Pain Res. 2010 Oct 25;3:201-12. [PMID: 21197324]
  • Bishop ML, Duben-Engelkirk JL, Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott (1996).
  • Lehmann CA. Saunders Manual of Clinical Laboratory Science. Philadelphia. W.B. Saunders Company (1998).